<DOC>
	<DOCNO>NCT00370526</DOCNO>
	<brief_summary>The literature show approximately 40 % individual receive cardiac resynchronization therapy ( CRT ) device symptomatic congestive heart failure ( CHF ) clinical benefit device . The HEAL-HF protocol compare outcomes conventionally place CRT device magnetically place CRT device assess hemodynamic parameter magnetic placement leave ventricular ( LV ) lead .</brief_summary>
	<brief_title>HEAL-HF : A Cardiac Resynchronization Therapy ( CRT ) Outcomes Study</brief_title>
	<detailed_description>Baseline information obtain include QoL , 6-minute walk , echo measurement . The patient randomize receive conventionally-placed LV lead randomize receive magnetically-placed LV lead . The magnetic group acute hemodynamics assessed procedure evaluate best response leave ventricle pacing . Patients follow 6 month re-evaluation baseline test assess change HF symptom . Adverse event also record follow-up period .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Ischemic cardiomyopathy Ejection Fraction ( EF ) &lt; = 35 % QRS duration &gt; = 120 msec Standard heart failure ( HF ) oral medication least 1 month Evidence mechanical dyssynchrony NYHA Class III IV Persistent chronic atrial fibrillation ( AF ) Hemodynamically unstable uncontrolled arrhythmia Unstable angina Aortic valve ( AV ) insufficiency stenosis Mitral valve ( MV ) regurgitation &gt; 2+ Active infection Contraindications heparin Dependence atrial pacing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>heart failure</keyword>
	<keyword>resynchronization</keyword>
	<keyword>CRT</keyword>
	<keyword>Bi-V pacemaker</keyword>
	<keyword>LV lead placement</keyword>
	<keyword>hemodynamic assessment</keyword>
	<keyword>CRT Outcomes</keyword>
</DOC>